MP Healthcare Venture Management
MPH is the venture capital arm of Mitsubishi Tanabe Pharma Corp
Business Model:
Revenue: $23.8M
Employees: 51-200
Rankings
Industries / Tags:
Detailed MP Healthcare Venture Management Information
Geographic Data
Address: 33 Arch St
City: Boston
State: MA
Zip: 02110
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
6,672,671Website Global Rank
764Website Monthly Traffic
Twitter Followers
Description
MPH is the venture capital arm of Mitsubishi Tanabe Pharma Corporation (MTPC). MPH invests in innovative companies developing novel therapeutics, platform technologies, and vaccines.
Contact Phone:
+16177374690
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2020 | Korro Bio | Series A | 0 |
| 5/2020 | QurAlis | Series A | 0 |
| 5/2010 | Pronota | Series B | 0 |
| 1/2012 | Pronota | Series C | 4.8M |
| 11/2015 | Viridian Therapeutics | Series C | 0 |
| 4/2017 | Forge Therapeutics | Series A | 0 |
| 4/2018 | QurAlis | Seed Round | - |
| 11/2018 | Ribometrix | Series A | 30M |
| 11/2018 | QurAlis | Seed Round | 5.5M |
| 9/2021 | SOLA Biosciences | Seed Round | - |
| 4/2011 | F-Star Therapeutics | Venture Round | 0 |
| 12/2013 | Covagen | Series B | 0 |
| 9/2021 | SOLA Biosciences | Seed Round | - |
| 3/2015 | Thrasos | Series D | 21M |
| 10/2009 | Covagen | Seed Round | - |
| 5/2011 | Genkyotex | Series C | 20.4M |
| 11/2010 | Covagen | Series A | 6.3M |
| 10/2017 | Ribometrix | Seed Round | 7.5M |
| 1/2012 | Syndexa Pharmaceuticals | Series B | 8.5M |
| 7/2012 | Genkyotex | Series C | 25.6M |
| 11/2009 | FerroKin Biosciences | Venture Round | 15M |
| 1/2010 | F-Star Therapeutics | Series A | 11.5M |
| 1/2009 | Intradigm Corporation | Series B | 0 |
| 12/2020 | Capsigen | Seed Round | - |
| 10/2012 | Thrasos | Series C | 35M |
| 10/2009 | Pronota | Series B | 1.9M |
| 6/2011 | PharmEste | Series B | 0 |
| 10/2012 | Genocea Biosciences | Series C | 30M |
| 6/2010 | FerroKin Biosciences | Series B | 12M |
| 3/2023 | QurAlis | Series B | 0 |
| 5/2023 | PharmEnable | Seed Round | 0 |
| 5/2021 | Libero Thera | Venture Round | 0 |
| 1/2021 | Blacksmith Medicines | Seed Round | - |
| 10/2013 | F-Star Therapeutics | Series A | 0 |
| 1/2011 | Genocea Biosciences | Series B | 35M |
| 12/2009 | Genocea Biosciences | Series B | 25.7M |
| 9/2016 | Rigontec | Series A | 16.9M |
| 1/2022 | Korro Bio | Series B | 0 |
| 9/2019 | Ribometrix | Equity | 7.8M |
| 4/2019 | Sonde Health | Series A | 0 |
| 4/2021 | Outrun TX | Seed Round | - |
| 5/2023 | PharmEnable | Seed Round | 0 |
| 3/2023 | QurAlis | Series B | 0 |
| 1/2022 | Korro Bio | Series B | 0 |
| 9/2021 | SOLA Biosciences | Seed Round | - |
| 5/2021 | Libero Thera | Venture Round | 0 |
| 4/2021 | Outrun TX | Seed Round | - |
| 1/2021 | Blacksmith Medicines | Seed Round | - |
| 12/2020 | Capsigen | Seed Round | - |
| 9/2020 | Korro Bio | Series A | 0 |
| 5/2020 | QurAlis | Series A | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
